Kenjiro Okubo, Toshiyuki Kudo, Sae Yoshihara, Yu Nakabayashi, Kana Nakauchi, Akimi Tanaka, Moe Saito, Ayumi Tsujisawa, Hitomi Goda, Yoshiaki Yamagishi, et al. Physiologically based pharmacokinetic model analysis of the inhibitory effect of vonoprazan on the metabolic activation of proguanil. Drug Metabolism and Pharmacokinetics. 2024. 54. 100537-100537
Tomohisa Nakada, Toshiyuki Kudo, Kiyomi Ito. Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition. Drug metabolism and disposition: the biological fate of chemicals. 2023
Toshiyuki Hikita, Hitomi Goda, Yasuko Ogawa, Toshiyuki Kudo, Kiyomi Ito. Caffeine consumption as a risk factor for childhood and adolescence migraine. Pediatrics international : official journal of the Japan Pediatric Society. 2023. 65. 1. e15429
Kentaro Ohta, Nobuko Matsushima, Hiromi Tanii, Herta Crauwels, Toshiyuki Kudo, Kiyomi Ito. Pharmacokinetics and safety of rilpivirine in healthy Japanese subjects and exploration of ethnic sensitivity of rilpivirine pharmacokinetics with physiologically based pharmacokinetic model approach. Drug metabolism and pharmacokinetics. 2021. 41. 100422-100422
Toshiyuki Kudo, Yuya Ozaki, Eri Hotta, Aya Matsubara, Kiyomi Ito. EFFECT OF BUFFER CONDITIONS ON CYP2C8-MEDIATED 6 alpha-HYDROXYLATION OF PACLITAXEL BY HUMAN LIVER MICROSOMES. DRUG METABOLISM REVIEWS. 2015. 47. 193-194
Toshiyuki Kudo, Akihiro Hisaka, Yuchi Sugiyama, Kiyomi Ito. Analysis of the repaglinide concentration increase produced by gemfibrozil and itraconazole based on the inhibition of the hepatic uptake transporter and metabolic enzymes. FASEB JOURNAL. 2014. 28. 1
Toshiyuki Kudo, Akihiro Hisaka, Yuichi Sugiyama, Kiyomi Ito. ANALYSIS OF THE GLIBENCLAMIDE CONCENTRATION INCREASE BY CLARITHROMYCIN BASED ON THE INHIBITION OF HEPATIC UPTAKE TRANSPORTER AND METABOLIC ENZYMES USING A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL. DRUG METABOLISM REVIEWS. 2012. 44. 73-74
2014/01 - Drug Metabolism Division of ASPET James R. Gillette Drug Metabolism Best Paper of 2013 Analysis of the Repaglinide Concentration Increase Produced by Gemfibrozil and Itraconazole Based on the Inhibition of the Hepatic Uptake Transporter and Metabolic Enzymes